Palisades Hudson Asset Management L.P. trimmed its stake in Juniper Networks, Inc. (NYSE:JNPR – Free Report) by 5.1% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,308 shares of the network equipment provider’s stock after selling 449 shares during the quarter. Palisades Hudson Asset Management L.P.’s holdings in Juniper Networks were worth $324,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors also recently modified their holdings of the company. Pacer Advisors Inc. grew its position in Juniper Networks by 14,314.7% in the 2nd quarter. Pacer Advisors Inc. now owns 4,832,105 shares of the network equipment provider’s stock worth $176,179,000 after purchasing an additional 4,798,583 shares during the last quarter. Magnetar Financial LLC bought a new position in Juniper Networks during the first quarter worth about $86,494,000. Canada Pension Plan Investment Board boosted its position in shares of Juniper Networks by 859.1% during the first quarter. Canada Pension Plan Investment Board now owns 836,900 shares of the network equipment provider’s stock worth $31,016,000 after purchasing an additional 749,641 shares in the last quarter. Gabelli Funds LLC bought a new position in Juniper Networks in the first quarter valued at approximately $23,379,000. Finally, Natixis lifted its position in Juniper Networks by 1,524.4% in the 1st quarter. Natixis now owns 470,137 shares of the network equipment provider’s stock valued at $17,423,000 after acquiring an additional 441,194 shares in the last quarter. Institutional investors and hedge funds own 91.95% of the company’s stock.
Juniper Networks Trading Up 0.1 %
Shares of NYSE JNPR traded up $0.02 during trading on Monday, reaching $39.02. The company had a trading volume of 120,692 shares, compared to its average volume of 3,560,172. The company has a quick ratio of 1.23, a current ratio of 1.69 and a debt-to-equity ratio of 0.36. The stock has a market cap of $12.84 billion, a P/E ratio of 51.32, a PEG ratio of 12.21 and a beta of 0.93. The company’s fifty day moving average price is $38.87 and its 200-day moving average price is $37.19. Juniper Networks, Inc. has a 12 month low of $25.83 and a 12 month high of $39.79.
Juniper Networks Announces Dividend
Wall Street Analyst Weigh In
A number of equities analysts recently commented on JNPR shares. StockNews.com initiated coverage on Juniper Networks in a report on Monday, September 16th. They set a “hold” rating for the company. Barclays cut their price objective on shares of Juniper Networks from $40.00 to $37.00 and set an “equal weight” rating for the company in a report on Friday. Needham & Company LLC restated a “hold” rating on shares of Juniper Networks in a research report on Friday, July 26th. Rosenblatt Securities reiterated a “neutral” rating and set a $40.00 price objective on shares of Juniper Networks in a research note on Friday. Finally, Citigroup reissued a “neutral” rating and issued a $40.00 target price on shares of Juniper Networks in a report on Monday, September 23rd. Eight investment analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $39.50.
View Our Latest Stock Report on JNPR
About Juniper Networks
Juniper Networks, Inc designs, develops, and sells network products and services worldwide. The company offers routing products, such as ACX series universal access routers to deploy high-bandwidth services; MX series Ethernet routers that function as a universal edge platform; PTX series packet transport routers; wide-area network SDN controllers; and session smart routers.
See Also
- Five stocks we like better than Juniper Networks
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
- Which Wall Street Analysts are the Most Accurate?
- 3 Stocks That Are Potential Takeover Targets in 2025
Receive News & Ratings for Juniper Networks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Juniper Networks and related companies with MarketBeat.com's FREE daily email newsletter.